EpiDiP/NanoDiP: a versatile unsupervised machine learning edge computing platform for epigenomic tumour diagnostics.

Artificial intelligence Copy number profiling Cryptocurrency miner Digital pathology Dimension reduction Edge computing Epigenetics Intraoperative Methylation Methylation sequencing Methylome Microarray Nanopore sequencing Oncology Same-day classification SoC Tumour UMAP Unsupervised machine learning gpGPU

Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
04 Apr 2024
Historique:
received: 25 11 2023
accepted: 11 03 2024
medline: 5 4 2024
pubmed: 5 4 2024
entrez: 4 4 2024
Statut: epublish

Résumé

DNA methylation analysis based on supervised machine learning algorithms with static reference data, allowing diagnostic tumour typing with unprecedented precision, has quickly become a new standard of care. Whereas genome-wide diagnostic methylation profiling is mostly performed on microarrays, an increasing number of institutions additionally employ nanopore sequencing as a faster alternative. In addition, methylation-specific parallel sequencing can generate methylation and genomic copy number data. Given these diverse approaches to methylation profiling, to date, there is no single tool that allows (1) classification and interpretation of microarray, nanopore and parallel sequencing data, (2) direct control of nanopore sequencers, and (3) the integration of microarray-based methylation reference data. Furthermore, no software capable of entirely running in routine diagnostic laboratory environments lacking high-performance computing and network infrastructure exists. To overcome these shortcomings, we present EpiDiP/NanoDiP as an open-source DNA methylation and copy number profiling suite, which has been benchmarked against an established supervised machine learning approach using in-house routine diagnostics data obtained between 2019 and 2021. Running locally on portable, cost- and energy-saving system-on-chip as well as gpGPU-augmented edge computing devices, NanoDiP works in offline mode, ensuring data privacy. It does not require the rigid training data annotation of supervised approaches. Furthermore, NanoDiP is the core of our public, free-of-charge EpiDiP web service which enables comparative methylation data analysis against an extensive reference data collection. We envision this versatile platform as a useful resource not only for neuropathologists and surgical pathologists but also for the tumour epigenetics research community. In daily diagnostic routine, analysis of native, unfixed biopsies by NanoDiP delivers molecular tumour classification in an intraoperative time frame.

Identifiants

pubmed: 38576030
doi: 10.1186/s40478-024-01759-2
pii: 10.1186/s40478-024-01759-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

51

Informations de copyright

© 2024. The Author(s).

Références

Baettig F, Vlajnic T, Vetter M, Glatz K, Hench J, Frank S, Bihl M, Lopez R, Dobbie M, Heinzelmann-Schwarz V, Montavon C (2019) Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response. J Immunother Cancer 7:281. https://doi.org/10.1186/s40425-019-0742-6
doi: 10.1186/s40425-019-0742-6 pubmed: 31672171 pmcid: 6824124
Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, Stichel D, Olar A, Engel NW, Lindenberg K, Harter PN, Braczynski AK, Plate KH, Dohmen H, Garvalov BK, Coras R, Hölsken A, Hewer E, Bewerunge-Hudler M, Schick M, Fischer R, Beschorner R, Schittenhelm J, Staszewski O, Wani K, Varlet P, Pages M, Temming P, Lohmann D, Selt F, Witt H, Milde T, Witt O, Aronica E, Giangaspero F, Rushing E, Scheurlen W, Geisenberger C, Rodriguez FJ, Becker A, Preusser M, Haberler C, Bjerkvig R, Cryan J, Farrell M, Deckert M, Hench J, Frank S, Serrano J, Kannan K, Tsirigos A, Brück W, Hofer S, Brehmer S, Seiz-Rosenhagen M, Hänggi D, Hans V, Rozsnoki S, Hansford JR, Kohlhof P, Kristensen BW, Lechner M, Lopes B, Mawrin C, Ketter R, Kulozik A, Khatib Z, Heppner F, Koch A, Jouvet A, Keohane C, Mühleisen H, Mueller W, Pohl U, Prinz M, Benner A, Zapatka M, Gottardo NG, Driever PH, Kramm CM, Müller HL, Rutkowski S, von Hoff K, Frühwald MC, Gnekow A, Fleischhack G, Tippelt S, Calaminus G, Monoranu C-M, Perry A, Jones C, Jacques TS, Radlwimmer B, Gessi M, Pietsch T, Schramm J, Schackert G, Westphal M, Reifenberger G, Wesseling P, Weller M, Collins VP, Blümcke I, Bendszus M, Debus J, Huang A, Jabado N, Northcott PA, Paulus W, Gajjar A, Robinson GW, Taylor MD, Jaunmuktane Z, Ryzhova M, Platten M, Unterberg A, Wick W, Karajannis MA, Mittelbronn M, Acker T, Hartmann C, Aldape K, Schüller U, Buslei R, Lichter P, Kool M, Herold-Mende C, Ellison DW, Hasselblatt M, Snuderl M, Brandner S, Korshunov A, von Deimling A, Pfister SM (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474. https://doi.org/10.1038/nature26000
doi: 10.1038/nature26000 pubmed: 29539639 pmcid: 6093218
Capper D, Stichel D, Sahm F, Jones DTW, Schrimpf D, Sill M, Schmid S, Hovestadt V, Reuss DE, Koelsche C, Reinhardt A, Wefers AK, Huang K, Sievers P, Ebrahimi A, Schöler A, Teichmann D, Koch A, Hänggi D, Unterberg A, Platten M, Wick W, Witt O, Milde T, Korshunov A, Pfister SM, von Deimling A (2018) Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol (Berl) 136:181–210. https://doi.org/10.1007/s00401-018-1879-y
doi: 10.1007/s00401-018-1879-y pubmed: 29967940
Chen Y, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, Gallinger S, Hudson TJ, Weksberg R (2013) Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8:203–209. https://doi.org/10.4161/epi.23470
doi: 10.4161/epi.23470 pubmed: 23314698 pmcid: 3592906
Djirackor L, Halldorsson S, Niehusmann P, Leske H, Capper D, Kuschel LP, Pahnke J, Due-Tønnessen BJ, Langmoen IA, Sandberg CJ, Euskirchen P, Vik-Mo EO (2021) Intraoperative DNA methylation classification of brain tumors impacts neurosurgical strategy. Neuro-Oncol Adv vdab149. https://doi.org/10.1093/noajnl/vdab149
doi: 10.1093/noajnl/vdab149
Euskirchen P, Bielle F, Labreche K, Kloosterman WP, Rosenberg S, Daniau M, Schmitt C, Masliah-Planchon J, Bourdeaut F, Dehais C, Marie Y, Delattre J-Y, Idbaih A (2017) Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing. Acta Neuropathol (Berl) 134:691–703. https://doi.org/10.1007/s00401-017-1743–5
doi: 10.1007/s00401-017-1743-5 pubmed: 28638988
Fortin J-P, Triche TJ, Hansen KD (2016) Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics btw691. https://doi.org/10.1093/bioinformatics/btw691
Gamaarachchi H, Lam CW, Jayatilaka G, Samarakoon H, Simpson JT, Smith MA, Parameswaran S (2020) GPU accelerated adaptive banded event alignment for rapid comparative nanopore signal analysis. BMC Bioinformatics 21:343. https://doi.org/10.1186/s12859-020-03697-x
doi: 10.1186/s12859-020-03697-x pubmed: 32758139 pmcid: 7430849
Gamaarachchi H, Samarakoon H, Jenner SP, Ferguson JM, Amos TG, Hammond JM, Saadat H, Smith MA, Parameswaran S, Deveson IW (2022) Fast nanopore sequencing data analysis with SLOW5. Nat Biotechnol 40:1026–1029. https://doi.org/10.1038/s41587-021-01147–4
doi: 10.1038/s41587-021-01147-4 pubmed: 34980914 pmcid: 9287168
Haefliger S, Tzankov A, Frank S, Bihl M, Vallejo A, Stebler J, Hench J (2021) NUT midline carcinomas and their differentials by a single molecular profiling method: a new promising diagnostic strategy illustrated by a case report. Virchows Arch Int J Pathol 478:1007–1012. https://doi.org/10.1007/s00428-020-02869–7
doi: 10.1007/s00428-020-02869-7
Hench J, Vlajnic T, Soysal SD, Obermann EC, Frank S, Muenst S (2022) An Integrated Epigenomic and genomic view on Phyllodes and Phyllodes-like breast tumors. Cancers 14:667. https://doi.org/10.3390/cancers14030667
doi: 10.3390/cancers14030667 pubmed: 35158935 pmcid: 8833410
Jurmeister P, Schöler A, Arnold A, Klauschen F, Lenze D, Hummel M, Schweizer L, Bläker H, Pfitzner BM, Mamlouk S, Sers C, Denkert C, Stichel D, Frost N, Horst D, von Laffert M, Capper D (2019) DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer. Mod Pathol. https://doi.org/10.1038/s41379-019-0207-y
doi: 10.1038/s41379-019-0207-y pubmed: 30723296
Jurmeister P, Bockmayr M, Seegerer P, Bockmayr T, Treue D, Montavon G, Vollbrecht C, Arnold A, Teichmann D, Bressem K, Schüller U, von Laffert M, Müller K-R, Capper D, Klauschen F (2019) Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases. Sci Transl Med 11:eaaw8513. https://doi.org/10.1126/scitranslmed.aaw8513
doi: 10.1126/scitranslmed.aaw8513 pubmed: 31511427
Jurmeister P, Glöß S, Roller R, Leitheiser M, Schmid S, Mochmann LH, Payá Capilla E, Fritz R, Dittmayer C, Friedrich C, Thieme A, Keyl P, Jarosch A, Schallenberg S, Bläker H, Hoffmann I, Vollbrecht C, Lehmann A, Hummel M, Heim D, Haji M, Harter P, Englert B, Frank S, Hench J, Paulus W, Hasselblatt M, Hartmann W, Dohmen H, Keber U, Jank P, Denkert C, Stadelmann C, Bremmer F, Richter A, Wefers A, Ribbat-Idel J, Perner S, Idel C, Chiariotti L, Della Monica R, Marinelli A, Schüller U, Bockmayr M, Liu J, Lund VJ, Forster M, Lechner M, Lorenzo-Guerra SL, Hermsen M, Johann PD, Agaimy A, Seegerer P, Koch A, Heppner F, Pfister SM, Jones DTW, Sill M, von Deimling A, Snuderl M, Müller K-R, Forgó E, Howitt BE, Mertins P, Klauschen F, Capper D (2022) DNA methylation-based classification of sinonasal tumors. Nat Commun 13:7148. https://doi.org/10.1038/s41467-022-34815–3
doi: 10.1038/s41467-022-34815-3 pubmed: 36443295 pmcid: 9705411
Karimi S, Zuccato JA, Mamatjan Y, Mansouri S, Suppiah S, Nassiri F, Diamandis P, Munoz DG, Aldape KD, Zadeh G (2019) The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care. Clin Epigenetics 11:185. https://doi.org/10.1186/s13148-019-0766–2
doi: 10.1186/s13148-019-0766-2 pubmed: 31806041 pmcid: 6896594
Koelsche C, Schrimpf D, Stichel D, Sill M, Sahm F, Reuss DE, Blattner M, Worst B, Heilig CE, Beck K, Horak P, Kreutzfeldt S, Paff E, Stark S, Johann P, Selt F, Ecker J, Sturm D, Pajtler KW, Reinhardt A, Wefers AK, Sievers P, Ebrahimi A, Suwala A, Fernández-Klett F, Casalini B, Korshunov A, Hovestadt V, Kommoss FKF, Kriegsmann M, Schick M, Bewerunge-Hudler M, Milde T, Witt O, Kulozik AE, Kool M, Romero-Pérez L, Grünewald TGP, Kirchner T, Wick W, Platten M, Unterberg A, Uhl M, Abdollahi A, Debus J, Lehner B, Thomas C, Hasselblatt M, Paulus W, Hartmann C, Staszewski O, Prinz M, Hench J, Frank S, Versleijen-Jonkers YMH, Weidema ME, Mentzel T, Griewank K, de Álava E, Martín JD, Gastearena MAI, Chang KT-E, Low SYY, Cuevas-Bourdier A, Mittelbronn M, Mynarek M, Rutkowski S, Schüller U, Mautner VF, Schittenhelm J, Serrano J, Snuderl M, Büttner R, Klingebiel T, Buslei R, Gessler M, Wesseling P, Dinjens WNM, Brandner S, Jaunmuktane Z, Lyskjær I, Schirmacher P, Stenzinger A, Brors B, Glimm H, Heining C, Tirado OM, Sáinz-Jaspeado M, Mora J, Alonso J, del Muro XG, Moran S, Esteller M, Benhamida JK, Ladanyi M, Wardelmann E, Antonescu C, Flanagan A, Dirksen U, Hohenberger P, Baumhoer D, Hartmann W, Vokuhl C, Flucke U, Petersen I, Mechtersheimer G, Capper D, Jones DTW, Fröhling S, Pfister SM, von Deimling A (2021) Sarcoma classification by DNA methylation profiling. Nat Commun 12:498. https://doi.org/10.1038/s41467-020-20603–4
doi: 10.1038/s41467-020-20603-4 pubmed: 33479225 pmcid: 7819999
Kuschel LP, Hench J, Frank S, Hench IB, Girard E, Blanluet M, Masliah-Planchon J, Misch M, Onken J, Czabanka M, Karau P, Ishaque N, Hain EG, Heppner F, Idbaih A, Behr N, Harms C, Capper D, Euskirchen P (2021) Robustmethylation-basedclassificationofbraintumorsusingnanoporesequencing.Oncology
Li H (2018) Minimap2: pairwise alignment for nucleotide sequences. Bioinforma Oxf Engl 34:3094–3100. https://doi.org/10.1093/bioinformatics/bty191
doi: 10.1093/bioinformatics/bty191
Moran S, Martínez-Cardús A, Sayols S, Musulén E, Balañá C, Estival-Gonzalez A, Moutinho C, Heyn H, Diaz-Lagares A, de Moura MC (2016) othersEpigeneticprofilingtoclassifycancerofunknownprimary:amulticentre,retrospectiveanalysis.LancetOncol17:1386–1395
Moudgil-Joshi J, Kaliaperumal C (2021) Letter regarding Louis et al: the 2021 WHO classification of tumors of the Central Nervous System: a summary. Neuro-Oncol 23:2120–2121. https://doi.org/10.1093/neuonc/noab190
doi: 10.1093/neuonc/noab190 pubmed: 34596667 pmcid: 8643450
Nestor CE, Ottaviano R, Reinhardt D, Cruickshanks HA, Mjoseng HK, McPherson RC, Lentini A, Thomson JP, Dunican DS, Pennings S, Anderton SM, Benson M, Meehan RR (2015) Rapid reprogramming of epigenetic and transcriptional profiles in mammalian culture systems. Genome Biol 16:11. https://doi.org/10.1186/s13059-014-0576-y
doi: 10.1186/s13059-014-0576-y pubmed: 25648825 pmcid: 4334405
Sahm F, Schrimpf D, Stichel D, Jones DT, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper D (2017) othersDNAmethylation-basedclassificationandgradingsystemformeningioma:amulticentre,retrospectiveanalysis.LancetOncol18:682–694
Saleh C, Jaszczuk P, Hund-Georgiadis M, Frank S, Cordier D, Hench IB, Todea A, Wasilewski A, Wilmes S, Grigioni G, Hench J (2020) Differentiation of rare brain tumors through unsupervised machine learning: clinical significance of in-depth methylation and copy number profiling illustrated through an unusual case of IDH wildtype glioblastoma. Clin Neuropathol. https://doi.org/10.5414/NP301305
doi: 10.5414/NP301305
Samarakoon H, Ferguson JM, Jenner SP, Amos TG, Parameswaran S, Gamaarachchi H, Deveson IW (2023) Flexible and efficient handling of nanopore sequencing signal data with slow5tools. Genome Biol 24:69. https://doi.org/10.1186/s13059-023-02910–3
doi: 10.1186/s13059-023-02910-3 pubmed: 37024927 pmcid: 10080837
Sittón-Candanedo I, Alonso RS, Corchado JM, Rodríguez-González S, Casado-Vara R (2019) A review of edge computing reference architectures and a new global edge proposal. Future Gener Comput Syst 99:278–294. https://doi.org/10.1016/j.future.2019.04.016
doi: 10.1016/j.future.2019.04.016
Vaisvila R, Ponnaluri VKC, Sun Z, Langhorst BW, Saleh L, Guan S, Dai N, Campbell MA, Sexton BS, Marks K, Samaranayake M, Samuelson JC, Church HE, Tamanaha E, Corrêa IR, Pradhan S, Dimalanta ET, Evans TC, Williams L, Davis TB (2021) Enzymatic methyl sequencing detects DNA methylation at single-base resolution from picograms of DNA. Genome Res 31:1280–1289. https://doi.org/10.1101/gr.266551.120
doi: 10.1101/gr.266551.120 pubmed: 34140313 pmcid: 8256858
van der Meulen R (2018) WhatEdgeComputingMeansforInfrastructureandOperationsLeaders.In:WhatEdgeComput.MeansInfrastruct.Oper.Lead. https://www.gartner.com/smarterwithgartner/what-edge-computing-means-for-infrastructure-and-operations-leaders.Accessed2Dec2022
Vermeulen C, Pagès-Gallego M, Kester L, Kranendonk MEG, Wesseling P, Verburg N, de Witt Hamer P, Kooi EJ, Dankmeijer L, van der Lugt J, van Baarsen K, Hoving EW, Tops BBJ, de Ridder J (2023) Ultra-fast deep-learned CNS tumour classification during surgery. Nature 622:842–849. https://doi.org/10.1038/s41586-023-06615–2
doi: 10.1038/s41586-023-06615-2 pubmed: 37821699 pmcid: 10600004
Volker Hovestadt MZ (2017) conumee
WHO Classification of Tumours Editorial Board (2021) Centralnervoussystemtumours,5thedition.InternationalAgencyforResearchonCancer,Lyon(France)
Williamson D, Schwalbe EC, Hicks D, Aldinger KA, Lindsey JC, Crosier S, Richardson S, Goddard J, Hill RM, Castle J, Grabovska Y, Hacking J, Pizer B, Wharton SB, Jacques TS, Joshi A, Bailey S, Clifford SC (2022) Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development. Cell Rep 40:111162. https://doi.org/10.1016/j.celrep.2022.111162
doi: 10.1016/j.celrep.2022.111162 pubmed: 35926460 pmcid: 9638015
Wu Z, Abdullaev Z, Pratt D, Chung H-J, Skarshaug S, Zgonc V, Perry C, Pack S, Saidkhodjaeva L, Nagaraj S, Tyagi M, Gangalapudi V, Valdez K, Turakulov R, Xi L, Raffeld M, Papanicolau-Sengos A, O’Donnell K, Newford M, Gilbert MR, Sahm F, Suwala AK, von Deimling A, Mamatjan Y, Karimi S, Nassiri F, Zadeh G, Ruppin E, Quezado M, Aldape K (2022) Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics. Neuro-Oncol 24:571–581. https://doi.org/10.1093/neuonc/noab227
doi: 10.1093/neuonc/noab227 pubmed: 34555175

Auteurs

Jürgen Hench (J)

Institut für Medizinische Genetik und Pathologie, Universitätsspital Basel, Schönbeinstr. 40, 4031, Basel, Switzerland. juergen.hench@usb.ch.

Claus Hultschig (C)

Institut für Medizinische Genetik und Pathologie, Universitätsspital Basel, Schönbeinstr. 40, 4031, Basel, Switzerland.

Jon Brugger (J)

Institut für Medizinische Genetik und Pathologie, Universitätsspital Basel, Schönbeinstr. 40, 4031, Basel, Switzerland.

Luigi Mariani (L)

Klinik für Neurochirurgie, Universitätsspital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.

Raphael Guzman (R)

Klinik für Neurochirurgie, Universitätsspital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.

Jehuda Soleman (J)

Klinik für Neurochirurgie, Universitätsspital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.

Severina Leu (S)

Klinik für Neurochirurgie, Universitätsspital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.

Miles Benton (M)

Human Genomics, Institute of Environmental Science and Research (ESR), 5022, Porirua, Wellington, New Zealand.

Irenäus Maria Stec (IM)

Institut für Medizinische Genetik und Pathologie, Universitätsspital Basel, Schönbeinstr. 40, 4031, Basel, Switzerland.

Ivana Bratic Hench (IB)

Institut für Medizinische Genetik und Pathologie, Universitätsspital Basel, Schönbeinstr. 40, 4031, Basel, Switzerland.

Per Hoffmann (P)

Life&Brain GmbH, Venusberg-Campus 1, Gebäude 76, 53127, Bonn, Germany.

Patrick Harter (P)

Institute of Neuropathology, Center for Neuropathology and Prion Research, Feodor- Lynen-Str. 23, 81377, München, Germany.

Katharina J Weber (KJ)

Neurological Institute (Edinger Institute), University Hospital, Heinrich-Hoffmann- Straße 7, 60528, Frankfurt am Main, Germany.
German Cancer Consortium (DKTK), Partner Site Frankfurt, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.

Anne Albers (A)

Institute of Neuropathology, University Hospital Münster, Pottkamp 2, 48149, Münster, Germany.

Christian Thomas (C)

Institute of Neuropathology, University Hospital Münster, Pottkamp 2, 48149, Münster, Germany.

Martin Hasselblatt (M)

Institute of Neuropathology, University Hospital Münster, Pottkamp 2, 48149, Münster, Germany.

Ulrich Schüller (U)

Forschungsinstitut Kinderkrebszentrum, Martinistrasse 52, 20251, Hamburg, Germany.
Department of Pediatric Hematology and Oncology, University Hospital Hamburg- Eppendorf, Hamburg, Germany.
Institute of Neuropathology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Department of Neuropathology, Department of Neuropathology, Charité- Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Lisa Restelli (L)

Institut für Medizinische Genetik und Pathologie, Universitätsspital Basel, Schönbeinstr. 40, 4031, Basel, Switzerland.

David Capper (D)

, 15. Luzerner Kantonsspital, Pathologie, Haus 27, 6000, Spitalstrasse, Luzern 16, Switzerland.

Ekkehard Hewer (E)

Institut universitaire de pathologie, Lausanne University Hospital (CHUV), University of Lausanne, Rue du Bugnon 25, 1011, Lausanne, Switzerland.

Joachim Diebold (J)

, 15. Luzerner Kantonsspital, Pathologie, Haus 27, 6000, Spitalstrasse, Luzern 16, Switzerland.

Danijela Kolenc (D)

, 15. Luzerner Kantonsspital, Pathologie, Haus 27, 6000, Spitalstrasse, Luzern 16, Switzerland.

Ulf C Schneider (UC)

Klinik für Neurochirurgie, Luzerner Kantonsspital, Haus 31, 6000, 16, Spitalstrasse, Luzern, Switzerland.

Elisabeth Rushing (E)

, 15. Luzerner Kantonsspital, Pathologie, Haus 27, 6000, Spitalstrasse, Luzern 16, Switzerland.
Medica Pathologie Zentrum Zürich, Hottingerstrasse 9 / 11, 8032, Zürich, Switzerland.

Rosa Della Monica (R)

CEINGE-Biotecnologie Avanzate, Via Gaetano Salvatore, 486 - 80145, Napoli, Italy.

Lorenzo Chiariotti (L)

CEINGE-Biotecnologie Avanzate, Via Gaetano Salvatore, 486 - 80145, Napoli, Italy.

Martin Sill (M)

Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Consortium for Translational Cancer Research (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

Daniel Schrimpf (D)

Department of Neuropathology, Institute of Neuropathology, University Hospital Heidelberg, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

Andreas von Deimling (A)

Department of Neuropathology, Institute of Neuropathology, University Hospital Heidelberg, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

Felix Sahm (F)

Department of Neuropathology, Institute of Neuropathology, University Hospital Heidelberg, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
, 23. DKFZ, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

Christian Kölsche (C)

Pathologisches Institut der LMU, Thalkirchner Str. 36, 80337, München, Germany.

Markus Tolnay (M)

Institut für Medizinische Genetik und Pathologie, Universitätsspital Basel, Schönbeinstr. 40, 4031, Basel, Switzerland.

Stephan Frank (S)

Institut für Medizinische Genetik und Pathologie, Universitätsspital Basel, Schönbeinstr. 40, 4031, Basel, Switzerland. stephan.frank@usb.ch.

Classifications MeSH